Literature DB >> 6253988

Predicted structure of two adenovirus tumor antigens.

M Perricaudet, J M Le Moullec, U Pettersson.   

Abstract

Early adenovirus type 2(Ad2) mRNA sequences have been cloned by using the pBR322 plasmid as a vector. Two clones that include sequences from region E1B were identified and their DNAs were characterized by hybridization, restriction enzyme cleavage, and DNA sequence analysis. The results showed that the clones were derived from two different spliced mRNAs. By combining our results with the established DNA sequence for region E1B of the closely related adenovirus type 5[Maat, J., van Beveren, C.P. & van Ormondt, H. (1980) Gene, in press] it was possible to deduce the structure of a 13S and a 22S mRNA. The two mRNAs differ from each other by the size of their intervening sequences. If translation starts at the first AUG following the cap, the 22S mRNA encodes a Mr 67,000 polypeptide that is terminated by a UGA stop codon located immediately before the splice, whereas the 13S mRNA encodes a Mr 20,000 polypeptide that is translated in different reading frames before and after the splice. The Mr 20,000 and 67,000 polypeptides correspond in molecular weight to two proteins that invariably are precipitated from infected cell extracts by antisera from animals carrying adenovirus-induced tumors.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6253988      PMCID: PMC349709          DOI: 10.1073/pnas.77.7.3778

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Mapping of adenovirus 2 RNA sequences in lytically infected cells and transformed cell lines.

Authors:  P A Sharp; P H Gallimore; S J Flint
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

2.  Studies on in vitro transformation by DNA and DNA fragments of human adenoviruses and simian virus 40.

Authors:  F L Graham; P J Abrahams; C Mulder; H L Heijneker; S O Warnaar; F A De Vries; W Fiers; A J Van Der Eb
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

3.  Hybridization maps of early and late messenger RNA sequences on the adenovirus type 2 genome.

Authors:  U Pettersson; C Tibbetts; L Philipson
Journal:  J Mol Biol       Date:  1976-03-15       Impact factor: 5.469

4.  An amazing sequence arrangement at the 5' ends of adenovirus 2 messenger RNA.

Authors:  L T Chow; R E Gelinas; T R Broker; R J Roberts
Journal:  Cell       Date:  1977-09       Impact factor: 41.582

5.  A new method for sequencing DNA.

Authors:  A M Maxam; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

6.  Loop structures in hybrids of early RNA and the separated strands of adenovirus DNA.

Authors:  G R Kitchingman; S P Lai; H Westphal
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

7.  Viral DNA in transformed cells. II. A study of the sequences of adenovirus 2 DNA IN NINE LINES OF TRANSFORMED RAT CELLS USING SPECIFIC FRAGMENTS OF THE VIRAL GENOME;.

Authors:  P H Gallimore
Journal:  J Mol Biol       Date:  1974-10-15       Impact factor: 5.469

8.  Amount of viral DNA in the genome of cells transformed by adenovirus type 2.

Authors:  U Pettersson; J Sambrook
Journal:  J Mol Biol       Date:  1973-01       Impact factor: 5.469

9.  Transformation with specific fragments of adenovirus DNAs. I. Isolation of specific fragments with transforming activity of adenovirus 2 and 5 DNA.

Authors:  A J Van der Eb; C Mulder; F L Graham; A Houweling
Journal:  Gene       Date:  1977       Impact factor: 3.688

10.  Spliced segments at the 5' terminus of adenovirus 2 late mRNA.

Authors:  S M Berget; C Moore; P A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

View more
  17 in total

1.  Identification of adenovirus type 2 early region 1B proteins that share the same amino terminus as do the 495R and 155R proteins.

Authors:  J B Lewis; C W Anderson
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

2.  mRNAs from human adenovirus 2 early region 4.

Authors:  A Virtanen; P Gilardi; A Näslund; J M LeMoullec; U Pettersson; M Perricaudet
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

3.  In vitro synthesis of adenovirus type 5 T antigens. II. Translation of virus-specific RNA from cells transformed by fragments of adenovirus type 5 DNA.

Authors:  H Jochemsen; J J Hertoghs; J H Lupker; A Davis; A J van der Eb
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

4.  Transcription of adenovirus 5 early region 1b is elevated in permissive cells infected by a mutant with an upstream deletion.

Authors:  D J Spector
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

5.  Enhanced expression of adenovirus transforming proteins.

Authors:  R B Gaynor; A Tsukamoto; C Montell; A J Berk
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

6.  Early region 1B of adenovirus 2 encodes two coterminal proteins of 495 and 155 amino acid residues.

Authors:  C W Anderson; R C Schmitt; J E Smart; J B Lewis
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

7.  Transformation of rodent cells by DNA extracted from transformation-defective adenovirus mutants.

Authors:  D T Rowe; F L Graham
Journal:  J Virol       Date:  1983-06       Impact factor: 5.103

8.  The sequence of the 3' non-coding region of the hexon mRNA discloses a novel adenovirus gene.

Authors:  G Akusjärvi; J Zabielski; M Perricaudet; U Pettersson
Journal:  Nucleic Acids Res       Date:  1981-01-10       Impact factor: 16.971

9.  Control of adenovirus E1B mRNA synthesis by a shift in the activities of RNA splice sites.

Authors:  C Montell; E F Fisher; M H Caruthers; A J Berk
Journal:  Mol Cell Biol       Date:  1984-05       Impact factor: 4.272

10.  Analysis of adenovirus transforming proteins from early regions 1A and 1B with antisera to inducible fusion antigens produced in Escherichia coli.

Authors:  K R Spindler; D S Rosser; A J Berk
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.